Darren Smith
Vermögen: 118 976 $ am 31.07.2026
Vermögen: 118 976 $ am 31.07.2026
Darren Smith is currently Director at Telix QSAM, Inc., Co-Managing Director at Rhine Pharma GmbH, Member at the Australian Institute of Co. Directors, and Group Chief Financial Officer at Telix Pharmaceuticals Ltd. since 2022.
Formerly, Mr. Smith was Global Chief Financial Officer & Secretary at Sirtex Medical Pty Ltd. from 2009 to 2019.
Education includes an undergraduate degree from the University of Western Sydney and an MBA from the Australian Graduate School of Management.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.03.2026 | 11 921 ( 0 % ) | 118 976 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Finanzdirektor/CFO | 31.07.2022 |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| SIRTEX MEDICAL LIMITED | Finanzdirektor/CFO | 01.03.2019 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Sirtex Medical Pty Ltd.
Sirtex Medical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of treatment for liver cancer | Commercial Services |
University of Western Sydney
University of Western Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Australian Graduate School of Management
Australian Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen